PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.36%
Negative revenue growth while MTDR stands at 37.19%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
7.74%
Gross profit growth under 50% of MTDR's 53.65%. Michael Burry would be concerned about a severe competitive disadvantage.
20.56%
EBIT growth below 50% of MTDR's 61.76%. Michael Burry would suspect deeper competitive or cost structure issues.
20.56%
Operating income growth under 50% of MTDR's 61.76%. Michael Burry would be concerned about deeper cost or sales issues.
-92.95%
Negative net income growth while MTDR stands at 57.21%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-64.64%
Negative EPS growth while MTDR is at 57.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-64.64%
Negative diluted EPS growth while MTDR is at 57.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.96%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-62.50%
Negative OCF growth while MTDR is at 6.34%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-708.16%
Negative FCF growth while MTDR is at 16.73%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-6.27%
Negative 10Y revenue/share CAGR while MTDR stands at 1350.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
300.94%
5Y revenue/share CAGR under 50% of MTDR's 1350.60%. Michael Burry would suspect a significant competitive gap or product weakness.
-9.00%
Negative 3Y CAGR while MTDR stands at 734.22%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-67.83%
Negative 10Y OCF/share CAGR while MTDR stands at 568.94%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-80.97%
Negative 5Y OCF/share CAGR while MTDR is at 568.94%. Joel Greenblatt would question the firm’s operational model or cost structure.
-76.64%
Negative 3Y OCF/share CAGR while MTDR stands at 51.13%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-87.90%
Negative 10Y net income/share CAGR while MTDR is at 2685.96%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-68.44%
Negative 5Y net income/share CAGR while MTDR is 2685.96%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
179.97%
Below 50% of MTDR's 694.29%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
6.74%
Below 50% of MTDR's 70.06%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-40.91%
Negative 5Y equity/share growth while MTDR is at 70.06%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-41.05%
Negative 3Y equity/share growth while MTDR is at 85.96%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
70.89%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-66.21%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-66.21%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
51.21%
Our AR growth while MTDR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
15.41%
Asset growth 1.25-1.5x MTDR's 12.44%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.97%
Under 50% of MTDR's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
15.15%
Debt shrinking faster vs. MTDR's 36.00%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-5.69%
We cut SG&A while MTDR invests at 7.85%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.